aminopterin has been researched along with Recrudescence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altuntaş, F; Çakar, MK; Dal, MS; Doğan, M; İskender, D; Merdin, A; Ulu, BU | 1 |
| Arranto, C; Halter, J; Tzankov, A | 1 |
| Hall, CP; Harutyunyan, N; Kang, MH; Lock, RB; Papa, RA | 1 |
| Duffull, SB; Fleisher, M; Hamlin, P; Horwitz, S; Mould, DR; Neylon, E; O'Connor, OA; Saunders, ME; Sirotnak, F; Sweeney, K | 1 |
| Fleisher, M; Hamelers, R; Hamlin, P; Horwitz, S; Macgregor-Cortelli, B; Mastrella, J; Moskowitz, CH; Mould, DR; Neylon, E; O'Connor, OA; Patterson, M; Portlock, C; Sarasohn, D; Saunders, M; Seshan, VE; Sirotnak, F; Zelenetz, AD | 1 |
| Bartlett, N; Coiffier, B; Foss, F; Furman, RR; Haioun, C; Horwitz, SM; Koutsoukos, T; O'Connor, OA; Pinter-Brown, LC; Popplewell, L; Pro, B; Shustov, A | 1 |
| Barbarotta, L; Foss, F; Parker, T | 1 |
| Cole, PD; Drachtman, RA; Drapala, DA; Glod, J; Kamen, BA; Lisi, S; Masterson, M; Smith, AK; Zebala, JA | 1 |
| Pochedly, C | 1 |
1 review(s) available for aminopterin and Recrudescence
| Article | Year |
|---|---|
Pralatrexate: treatment of T-cell non-Hodgkin's lymphoma.
Topics: Aminopterin; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Lymphoma, T-Cell; Recurrence | 2013 |
3 trial(s) available for aminopterin and Recrudescence
| Article | Year |
|---|---|
Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Constipation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Folic Acid Antagonists; Humans; Lymphoma, T-Cell; Male; Middle Aged; Recurrence; Remission Induction; Stomatitis; Treatment Outcome; Weight Loss; Young Adult | 2009 |
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Folic Acid Antagonists; Humans; Middle Aged; Mycosis Fungoides; Prognosis; Recurrence; Retrospective Studies; Survival Analysis | 2012 |
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
Topics: Adolescent; Aminopterin; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Child; Child, Preschool; Drug Overdose; Erythrocytes; Female; Fever; Folic Acid Antagonists; Gastrointestinal Diseases; Humans; Leucovorin; Male; Methotrexate; Neurotoxicity Syndromes; Pilot Projects; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Outcome | 2008 |
5 other study(ies) available for aminopterin and Recrudescence
| Article | Year |
|---|---|
Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment.
Topics: Aged; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Recurrence | 2019 |
Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate.
Topics: Aged; Aminopterin; Antineoplastic Agents; Dendritic Cells; Humans; Male; Myeloproliferative Disorders; Recurrence; Skin Neoplasms; Time Factors; Treatment Outcome | 2017 |
Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma.
Topics: Aminopterin; Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Humans; Inhibitory Concentration 50; Lymphoma; Methotrexate; Mice; Mice, SCID; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Xenograft Model Antitumor Assays | 2009 |
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Area Under Curve; Biomarkers; Body Size; Drug Administration Schedule; Female; Folic Acid Antagonists; Hodgkin Disease; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Methylmalonic Acid; Middle Aged; Models, Statistical; Mucositis; Predictive Value of Tests; Recurrence; Severity of Illness Index; Vitamin B 12 | 2009 |
Dr. James A. Wolff. II. First successful chemotherapy of acute leukemia.
Topics: Acute Disease; Aminopterin; Bacterial Infections; Bone Marrow Examination; Child; History, 20th Century; Humans; Leukemia; Nitrogen Mustard Compounds; Recurrence; United States | 1984 |